X T L Biopharmaceuticals reported $20.8M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 5M Sep/2025
Bioline Rx USD 16M 40M Sep/2025
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024